HSD17B12 and neuroblastoma: Our results confirmed that the silencing of HSD17B12 using both siRNA‐based strategies, induces an increase in membrane fluidity in SH‐SY5Y and SK‐N‐BE(2)C neuroblastoma cells, in agreement with the lipid‐ontology prediction (Figures6A and S11A, Supporting Information).